CorMedix Inc. Files Q1 2025 10-Q Report
Ticker: CRMD · Form: 10-Q · Filed: May 6, 2025 · CIK: 1410098
| Field | Detail |
|---|---|
| Company | Cormedix Inc. (CRMD) |
| Form Type | 10-Q |
| Filed Date | May 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
TL;DR
CorMedix filed its 10-Q for Q1 2025. Check financials.
AI Summary
CorMedix Inc. filed its quarterly report on Form 10-Q for the period ended March 31, 2025. The company, incorporated in Delaware, is involved in the pharmaceutical preparations industry. Its principal executive offices are located at 300 Connell Drive, Suite 4200, Berkeley Heights, NJ.
Why It Matters
This filing provides an update on CorMedix Inc.'s financial and operational status for the first quarter of 2025, which is crucial for investors to assess the company's performance and outlook.
Risk Assessment
Risk Level: low — This is a standard quarterly filing providing routine business and financial information.
Key Players & Entities
- CorMedix Inc. (company) — Registrant
- March 31, 2025 (date) — Quarterly period end date
- 300 Connell Drive, Suite 4200, Berkeley Heights, NJ 07922 (address) — Principal Executive Offices
- 20-5894890 (identifier) — I.R.S. Employer Identification No.
- 001-34673 (identifier) — Commission file number
FAQ
What is the primary business of CorMedix Inc.?
CorMedix Inc. is in the Pharmaceutical Preparations industry, SIC code 2834.
When is the fiscal year end for CorMedix Inc.?
The fiscal year end for CorMedix Inc. is December 31.
In which state was CorMedix Inc. incorporated?
CorMedix Inc. was incorporated in Delaware.
What is the filing date of this 10-Q report?
This 10-Q report was filed on May 6, 2025.
What is the telephone number for CorMedix Inc.'s principal executive offices?
The telephone number is (908) 517-9500.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 6, 2025 regarding CorMedix Inc. (CRMD).